After J&J News, Pfizer CEO Says It Can Deliver 10% More Vaccine Doses To U.S.

Albert Bourla, Pfizer CEO looks on at the Pfizer Kalamazoo Manufacturing Site February 19, 2021, in Portage, Michigan. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)

Pfizer CEO Albert Bourla on Tuesday said that the pharmaceutical giant ramped up production of its two-dose COVID-19 vaccine and can deliver 10 percent more doses to the U.S. than it previously agreed to produce by the end of May.

Bourla said Pfizer is also on track to deliver a total of 300 million doses to the country two weeks earlier than expected.

The Pfizer CEO’s announcement was issued the same day that the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) released a joint recommendation advising health care providers to stop administering Johnson & Johnson’s COVID-19 vaccine “out of an abundance of caution,” following an FDA advisory reporting that six women in the U.S. developed a rare blood-clotting disorder that led to the death of one woman and put another in critical condition.

During the FDA and CDC’s press conference on their announcement, acting FDA Commissioner Janet Woodcock said the pause was expected to last for “a matter of days.”

Shortly after the FDA and CDC held a press conference on its recommended pause of J&J vaccine distribution, several states moved to cease its distribution.

Earlier Tuesday, White House COVID-19 Response Coordinator Jeff Zients said that federal health agencies’ recommendation to pause J&J’s COVID-19 vaccines wouldn’t impede the Biden administration’s vaccine rollout program.

“This announcement will not have a significant impact on our vaccination plan: Johnson & Johnson vaccine makes up less than 5 percent of the recorded shots in arms in the United States to date,” Zients said in a statement.

Zients said that the 300 million doses of Pfizer and Moderna’s vaccines secured by the Biden administration indicated that the country has “more than enough supply” to continue its current rate of 3 million vaccinations per day. Zients also assured that President Biden’s goal of 200 million shots by his 100th day in office is still in reach.

Dear Reader,

When we asked recently what makes TPM different from other outlets, readers cited factors like honesty, curiosity, transparency, and our vibrant community. They also pointed to our ability to report on important stories and trends long before they are picked up by mainstream outlets; our ability to contextualize information within the arc of history; and our focus on the real-world consequences of the news.

Our unique approach to reporting and presenting the news, however, wouldn’t be possible without our readers’ support. That’s not just marketing speak, it’s true: our work would literally not be possible without readers deciding to become members. Not only does member support account for more than 80% of TPM’s revenue, our members have helped us build an engaged and informed community. Many of our best stories were born from reader tips and valuable member feedback.

We do what other news outlets can’t or won’t do because our members’ support gives us real independence.

If you enjoy reading TPM and value what we do, become a member today.

Sincerely,
TPM Staff
Latest News
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Reporters:
Newswriters:
Director of Audience:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: